Dr. Nyitray will discuss some of his recent research findings, including:
(1) The association between body mass index and anal canal human papillomavirus prevalence and persistence (The HIM Study);
(2) Factors associated with self-reported anal cancer screening history in men who have sex with men;
(3) Lack of HIV testing and dissatisfaction with HIV testing and counseling among men having sex with men in Hungary;
(4) Parental predictors of HPV vaccine initiation among low-income Hispanic females aged 11-17 years;
(5) A phase II clinical study to assess the feasibility of self and partner anal examinations to detect anal canal abnormalities including anal cancer;
(6) Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in a Sample of Young, Predominantly Black Men Who Have Sex With Men, Houston, Texas.
Speaker Biography - Alan G. Nyitray, Ph.D.
Alan G. Nyitray, Ph.D.
Department of Psychiatry and Behavioral Medicine, Cancer Center, Medical College of Wisconsin
Dr. Nyitray's primary research interest is in screening interventions for human papillomavirus (HPV)-associated disease with a focus on anal cancer. This research covers anal cancer and precancer screening interventions that seek to help gay, bisexual, and other men who have sex with men detect precancers or early invasive cancer when the cancer is much more treatable. His research initially focused on the epidemiology and natural history of HPV infection and HPV antibodies, estimating the prevalence, incidence, persistence, duration of infection, clearance, and the transmission potential of HPV among heterosexual men, gay and bisexual men, and heterosexual couples. Dr. Nyitray is also interested in creating HPV vaccine.
Seminars are FREE and open to the public. If you can not attend, Videotapes of Public Health seminars are archived through the UC Irvine OpenCourseWare program - please visit OpenCourseWare: http://ocw.uci.edu.